OTC Markets OTCQX - Delayed Quote USD
Medicenna Therapeutics Corp. (MDNAF)
0.7590
-0.0060
(-0.78%)
At close: April 23 at 2:19:39 PM EDT
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
19,134
36,446
23,456
42,252
Total Liabilities Net Minority Interest
13,943
6,960
2,621
4,107
Total Equity Gross Minority Interest
5,191
29,486
20,835
38,145
Total Capitalization
5,191
29,486
20,835
38,145
Common Stock Equity
5,191
29,486
20,835
38,145
Capital Lease Obligations
--
--
--
34
Net Tangible Assets
5,134
29,425
20,770
38,074
Working Capital
16,214
32,585
20,770
38,042
Invested Capital
5,191
29,486
20,835
38,145
Tangible Book Value
5,134
29,425
20,770
38,074
Total Debt
--
--
--
34
Share Issued
69,637.4690
69,637.4690
55,647.4790
53,547.7090
Ordinary Shares Number
69,637.4690
69,637.4690
55,647.4790
53,547.7090
3/31/2021 - 11/13/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NGENF NervGen Pharma Corp.
2.1300
-0.93%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
EPRX Eupraxia Pharmaceuticals Inc.
3.8400
-0.26%
NYMXF Nymox Pharmaceutical Corporation
0.1178
0.00%
TRVI Trevi Therapeutics, Inc.
6.27
+3.29%
PDSB PDS Biotechnology Corporation
1.2300
+6.96%
LRMR Larimar Therapeutics, Inc.
2.2600
-5.04%
MREO Mereo BioPharma Group plc
2.5600
+2.40%
XFOR X4 Pharmaceuticals, Inc.
0.2013
-0.84%
NAMSW NewAmsterdam Pharma Company N.V.
8.38
+4.75%